These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36561911)

  • 21. Roles for pharmacy in combatting counterfeit drugs.
    Ziance RJ
    J Am Pharm Assoc (2003); 2008; 48(4):e71-88; quiz e89-91. PubMed ID: 18653407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nationwide survey exploring physicians' and pharmacists' knowledge, awareness and perceptions regarding generic medicines in China.
    Qu J; Zuo W; Took RL; Schafermeyer KW; Lukas S; Wang S; Du L; Liu X; Gao Y; Li J; Pan H; Du X; Mei D; Zhang B
    BMC Health Serv Res; 2022 Aug; 22(1):1069. PubMed ID: 35987631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nationwide web-based survey of a sample of Italian community pharmacists' perceptions and opinions about online sales of medicines and falsified drugs.
    Lombardo S; Marino F; Cosentino M
    Pharm Pract (Granada); 2019; 17(4):1593. PubMed ID: 31897254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge, attitudes, and practices of pharmacists toward biosimilar medicines in Nigeria.
    Okoro RN; Hedima EW; Aguiyi-Ikeanyi CN
    J Am Pharm Assoc (2003); 2022; 62(1):79-85.e2. PubMed ID: 34654651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Counterfeit drugs as a gobal threat to health].
    Golocorbin Kon S; Mikov M
    Med Pregl; 2011; 64(5-6):285-90. PubMed ID: 21789919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the problem of counterfeit medications in the United Kingdom.
    Jackson G; Patel S; Khan S
    Int J Clin Pract; 2012 Mar; 66(3):241-50. PubMed ID: 22070229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of community pharmacists' readiness to implement the Falsified Medicines Directive (Directive 2011/62/EC): an English cross-sectional survey with geospatial analysis.
    Barrett R
    BMJ Open; 2020 Jan; 10(1):e033405. PubMed ID: 31924640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge, causes, and experience of inter-professional conflict and rivalry among healthcare professionals in Nigeria.
    Mohammed ENA
    BMC Health Serv Res; 2022 Mar; 22(1):320. PubMed ID: 35264179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge, attitudes and practices of community pharmacists on generic medicines in Palestine: a cross-sectional study.
    Shraim NY; Al Taha TA; Qawasmeh RF; Jarrar HN; Shtaya MAN; Shayeb LA; Sweileh WM
    BMC Health Serv Res; 2017 Dec; 17(1):847. PubMed ID: 29282055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.
    Mackey TK; Liang BA
    BMC Med; 2013 Oct; 11():233. PubMed ID: 24228892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An exploratory assessment of the legislative framework for combating counterfeit medicines in South Africa.
    Moshoeshoe RJ; Enslin GM; Katerere DR
    J Pharm Policy Pract; 2022 Jan; 15(1):3. PubMed ID: 34986899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mobile authentication service in Nigeria: An assessment of community pharmacists' acceptance and providers' views of successes and challenges of deployment.
    Oyetunde OO; Ogidan O; Akinyemi MI; Ogunbameru AA; Asaolu OF
    Pharm Pract (Granada); 2019; 17(2):1449. PubMed ID: 31275499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Counterfeit medicines: a growing threat].
    Barbereau S
    Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perceptions of current and potential public health involvement of pharmacists in developing nations: The case of Zimbabwe.
    Mdege ND; Chevo T; Toner P
    Res Social Adm Pharm; 2016; 12(6):876-884. PubMed ID: 26703215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating community pharmacists' perspectives and practices concerning generic medicines substitution in Saudi Arabia: A cross-sectional study.
    Alkhuzaee FS; Almalki HM; Attar AY; Althubiani SI; Almuallim WA; Cheema E; Hadi MA
    Health Policy; 2016 Dec; 120(12):1412-1419. PubMed ID: 28228231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors that influence pharmacists' efforts in addressing substance use in Nigeria: An exploratory study.
    Rotimi K; Edeh FK; Aiden J; Itiola AJ; Obamiro K
    Explor Res Clin Soc Pharm; 2022 Dec; 8():100189. PubMed ID: 36311825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
    Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B
    BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand.
    Babar ZU; Grover P; Stewart J; Hogg M; Short L; Seo HG; Rew A
    Res Social Adm Pharm; 2011 Sep; 7(3):294-305. PubMed ID: 21272551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.